Why is "Antipsychotic" trending?

Search Interest Perspective

• Beyond Weight Loss: Glucagon-Like Peptide-1 Receptor Agonists and Antipsychotic Adherence in Schizophrenia - Cureus
• Hyponatremia Risk Varies Among Second-Gen Antipsychotics - Medscape
• “Intranasal clozapine sol-gel formulation induces an antipsychotic effect at a fraction of a comparable oral therapeutic dose” | Translational Psychiatry - Nature
• Antipsychotic-Associated Hypothermia With Bradycardia and QT Prolongation in an Older Adult - Cureus
• Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databases - The Lancet
• Understanding the Long-Stay Antipsychotic Quality Measure - Provider magazine
• New measure likely to relax antipsychotic prescribing for certain hospice patients - McKnight's Long-Term Care News
• Case Report: Early onset pulmonary embolism following antipsychotic polypharmacy in an acute psychiatric setting - Frontiers
• [UPDATED] OIG Exposes ‘Alarming’ Misuse and Masking of Antipsychotic Drug Use in Nursing Homes - Skilled Nursing News
• HHS watchdog slams nursing homes’ antipsychotic drug use and schizophrenia diagnoses - STAT
• The STRIDE Weight Loss and Lifestyle Intervention for Individuals Taking Antipsychotic Medications: A Randomized Trial - Psychiatry Online
• Here's what to know about clozapine and other antipsychotic medicines used to treat schizophrenia - Mayo Clinic Press
• Evaluation of preclinical antipsychotic models used to support first-in-human clinical trials - British Pharmacological Society | Journals
• Cytokine changes in clinical high risk for psychosis population following antipsychotic medication - Nature
• Efficacy and Tolerability of Seven Antipsychotic Drugs in Acutely Ill Patients With Schizophrenia: A Randomized, Multicenter, Assessor-Blinded Trial - Psychiatry Online
• BREAKING: CMS ‘reviewing’ its policy on antipsychotic use in nursing homes, report says - McKnight's Long-Term Care News
• ‘Befuddling’: CMS MDS Overhaul Could Spike Antipsychotic Use Percentage, Complicate Quality Tracking - Skilled Nursing News
• When Literature Priors Are Removed: Clinical Rank Shifts and Transancestral Stability in Antipsychotic Low-Density Lipoprotein (LDL)-Risk Modelling - Cureus
• Ethical and Legal Considerations in the Refusal of Antipsychotic Treatment During Pregnancy: A Case Report - Cureus
• Antipsychotic Misuse: A Silent but Growing Public Health Hazard - Cureus
• Q&A: Supporting Patients Who Ask About Antipsychotic Discontinuation - Physician's Weekly
• CMS Updates Long Stay Antipsychotic Measure Calculation - AHCA/NCAL
• Metformin for the Prevention of Antipsychotic-Induced Weight Gain: The Optimal Strategy - Psychiatrist.com
• Antipsychotic-Induced Weight Gain in First-Episode Psychosis Patients: A Meta-Analysis of Differential Effects of Antipsychotic Medications - Psychiatry Online
• Should the practice of sedating the elderly in nursing homes be loosened? - The Washington Post
• Nursing homes falsely label patients schizophrenic to sedate them, OIG says - The Washington Post
• Antipsychotic medicines for schizophrenia: time to move forward - The Lancet
• Providers may be blindsided by unexpected CMS antipsychotic data changes, experts warn - McKnight's Long-Term Care News
• The sense and nonsense of antipsychotic combinations: A model for dopamine D - Nature
• FDA OKs First Non-Antipsychotic for Alzheimer’s Agitation - Medscape
• Why a Life-Threatening Sedative Is Being Prescribed More Often for Seniors - Rutgers University
• Canada is trying to cut overuse of antipsychotics in long-term care homes. But the rate is still high - CBC
• Antipsychotic Drugs That Cause Erectile Dysfunction - View axFF3eWXn - scchr.jp
• Multi-omics reveal critical roles of phosphatidylcholine and sphingomyelin in antipsychotic efficacy for schizophrenia - Nature
• Rethinking Antipsychotic Comparisons: The Role of Prior Exposure and Tolerability - Psychiatry Online
• Effect of antipsychotic consumption during pregnancy on risk of gestational diabetes development: a systematic review and meta-analysis - Frontiers
• WA man dies after not being able to get antipsychotic medication - ABC News & Headlines – Australian Broadcasting Corporation
• CMS Advised to Revise, Remove or Retire Antipsychotic Medication Quality Measure - Skilled Nursing News
• Use of antipsychotic meds in Maine nursing homes remains flat - newscentermaine.com
• US FDA approves Vanda's antipsychotic pill, shares climb - Reuters
• Antipsychotics Found to Increase Mortality Risk for Dementia Patients - Neurology Today
• Commentary: Does First Year Treatment With an Antipsychotic Lead to Long-Term Harm? - Mad In America
• Antipsychotics and other risk factors for mortality among people with schizophrenia during an extreme heat event: a population-based case-control study - Nature
• Off-label antipsychotic use widespread among older adults, study finds - Medical Xpress
• CMS unmoved by report calling for end of antipsychotics measure - McKnight's Long-Term Care News
• Coalition urges CMS to reform Long-Stay Antipsychotic Medication quality measure - McKnight's Long-Term Care News
• Can the Initial Antipsychotic Influence Years of Weight Gain? - Psychiatric Times
• Concerted elevations of cortical and striatal glutamate and GABA in antipsychotic-free individuals at clinical high-risk for psychosis - Nature
• Contrasting Typical and Atypical Antipsychotic Drugs - Psychiatry Online
• Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controls | Molecular Psychiatry - Nature
• Response Pharmaceuticals to Present Data on RDX-002 in Antipsychotic-Induced Weight Gain at the 2026 American Psychiatric Association Annual Meeting - Business Wire
• Atypical Antipsychotics to Manage Behavioral Symptoms in Autism Spectrum Disorder - American Academy Of Family Physicians | AAFP
• Interrelations between dopaminergic-, gabaergic- and glutamatergic neurotransmitters in antipsychotic-naïve psychosis patients and the association to initial treatment response | Molecular Psychiatry - Nature
• Is the Combination of GLP-1s and Clozapine Safe? - Medscape
• Exclusive | Lindsay Clancy trial spotlights controversial antipsychotic — and some claim it ‘ruined’ their lives - New York Post
• Saber Healthcare shares secret to sustained antipsychotic reductions - McKnight's Long-Term Care News
• Neuroplasticity, Antipsychotic Efficacy, Schizophrenia Risk Reduction With Doxycycline Exposure, and Cannabis and Alcohol Use Interactions - Psychiatry Online
• Cardiac Death Risk Rises With Both Antipsychotic Types - Psychiatry Online
• Risk Factors and Management Strategies for Antipsychotic-Induced Weight Gain: A Prescriptive Review for Clinicians - Psychiatry Online
• Demand for Antipsychotic Drugs in USA Size and Share Forecast Outlook 2025 to 2035 - Fact.MR
• Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use - Psychiatrist.com
• Antipsychotic prescribing in dementia does not follow NICE guidance, study shows - The Pharmaceutical Journal
• Here are all the powerful drugs found in Lindsay Clancy's system after she strangled her three kids - New York Post
• Updated rationale for the initial antipsychotic selection for patients with schizophrenia - Nature
• Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application - Psychiatry Online
• Advancing understanding of the mechanisms of antipsychotic-associated cognitive impairment to minimise harm: a call to action | Molecular Psychiatry - Nature
• A Concise Review of Phenothiazine Based Antipsychotic Drugs and Their Syntheses - Wiley Online Library
• Antipsychotic medications: a timeline of innovations and remaining challenges - Our World in Data
• Long-Term Antipsychotic Use and the Benefit-to-Harm Balance: More on the Risk of Relapse - Psychiatry Online
• Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review - Frontiers
• NAMI Ask the Expert: Facts, Myths and Misconceptions About Long-Acting Antipsychotic Medications - National Alliance on Mental Illness (NAMI)
• Molecular, physiological and functional features underlying antipsychotic medication use related cortical thinning - Nature
• Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia - Psychiatry Online
• Study suggests key to antipsychotic drug-induced obesity : Newsroom - UT Southwestern
• Lumateperone: A Truly Innovative Antipsychotic Medication? - Psychiatry Online
• Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes - Frontiers
• Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor | Molecular Psychiatry - Nature
• A systematic review of pharmacogenetic testing to guide antipsychotic treatment - Nature
• Prediction of antipsychotic drug efficacy for schizophrenia treatment based on neural features of the resting-state functional connectome | Translational Psychiatry - Nature
• Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons - Nature
• 9 Side Effects of Antipsychotic Medications - GoodRx
• The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research - Nature
• # Antipsychotic Erectile Dysfunction: Evidence-Based Strategies for Long-Term Wellness *IHeDINqkM* - Magiczny Kraków
• Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database - Nature
• Antipsychotic drugs work differently than scientists believed - Northwestern Now News
• Brown Study Challenges Common Perceptions of Antipsychotic Use in Nursing Homes - Brown University
• Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia - Nature
• New Guideline Calls for Metformin to Prevent Antipsychotic-Induced Weight Gain - Psychiatry Online
• The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective - Frontiers
• Antipsychotic Drugs Work Differently Than Scientists Believed - Northwestern University
• Addressing Obesity in Patients Taking Antipsychotics - Psychiatric Times
• Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders - Psychiatrist.com
• Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis - Frontiers
• Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’? - Frontiers
• Discontinuing Antipsychotics - Psychiatric Times
• Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia - Nature
• 11 Antipsychotics and Their Impact on Weight Gain By Dose - Psychiatrist.com
• Antipsychotic Use in Youths with ADHD Is Low, But Still Concerning - Columbia University Irving Medical Center
• Adjunctive Antipsychotic Therapies in the Treatment of Major Depressive Disorder - Psychiatry Advisor
• Antipsychotic withdrawal – an unrecognised and misdiagnosed problem - The Conversation